切换至 "中华医学电子期刊资源库"

中华产科急救电子杂志 ›› 2023, Vol. 12 ›› Issue (03) : 155 -158. doi: 10.3877/cma.j.issn.2095-3259.2023.03.008

胎盘植入性疾病

胎盘植入性疾病的不良结局及远期影响
张丽姿, 陈敦金()   
  1. 510150 广州医科大学附属第三医院妇产科 广东省产科重大疾病重点实验室 广州重症孕产妇救治中心 粤港澳母胎医学高校联合实验室 广东省母胎医学工程技术研究中心 广东省妇产疾病临床医学研究中心
  • 收稿日期:2023-07-17 出版日期:2023-08-18
  • 通信作者: 陈敦金
  • 基金资助:
    国家重点研发计划(2022YFC2704500、2022YFC2704501); 国家自然科学基金(81830045、82171666、82071652)

Adverse outcomes and long­term prognosis of placenta accreta spectrum disorders

Lizi Zhang, Dunjin Chen()   

  • Received:2023-07-17 Published:2023-08-18
  • Corresponding author: Dunjin Chen
引用本文:

张丽姿, 陈敦金. 胎盘植入性疾病的不良结局及远期影响[J/OL]. 中华产科急救电子杂志, 2023, 12(03): 155-158.

Lizi Zhang, Dunjin Chen. Adverse outcomes and long­term prognosis of placenta accreta spectrum disorders[J/OL]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2023, 12(03): 155-158.

胎盘植入性疾病的不良结局包括子宫破裂、产后出血、输血、子宫切除、多器官损伤和孕产妇死亡等。远期影响包括宫腔粘连、闭经、再次发生胎盘植入、心理障碍和不孕等。对于高危人群应加强产前评估,早期诊断并制定个体化治疗方案,积极进行多学科团队管理和干预,以有效降低不良结局的发生率,改善患者的远期预后。

Adverse outcomes of placenta accreta spectrum disorders include uterine rupture, postpartum hemorrhage, blood transfusion, hysterectomy, multiple organ damage, maternal death, etc. Long-term effects include intrauterine adhesions, amenorrhea, recurrent placenta accreta spectrum disorders, psychological disorders and infertility. For high-risk groups, prenatal assessment, early diagnosis and individualized treatment plan should be strengthened, and MDT team management and intervention should be actively carried out to effectively reduce the incidence of adverse outcomes and improve the long-term prognosis of patients.

[1]
Irving FC, Hertig AT. A study of placenta accreta[J]. Surg Gynecol Obstet193764:178-200.
[2]
Jauniaux E, Alfirevic Z, Bhide AG, et al. Placenta praevia and placenta accreta: diagnosis and management: Green-top Guideline No. 27a[J]. BJOG2019126(1):e1-e48.
[3]
Hobson SR, Kingdom JC, Murji A, et al. No.383-Screening, diagnosis, and management of placenta accreta spectrum disorders[J]. J Obstet Gynaecol Can201941(7):1035-1049.
[4]
Jauniaux E, Ayres-de-Campos D. FIGO consensus guidelines on placenta accreta spectrum disorders: introduction[J]. Int J Gynaecol Obstet2018140(3):261-264.
[5]
The Society of Gynecologic Oncology, American College of Obstetricians and Gynecologists, the Society for Maternal-Fetal Medicine. Placenta accreta spectrum[J]. Am J Obstet Gynecol, 2018, 219(6):B2-B16.
[6]
Fox H. Placenta accreta, 1945-1969[J]. Obstetrical & Gynecological Survey197227(7):475-490.
[7]
Luke RK, Sharpe JW, Greene RR. Placenta accreta: the adherent or invasive placenta[J]. Am J Obstet Gynecol196695(5):660-668.
[8]
Calì G, Timor-Tritsch IE, Palacios-Jaraquemada J, et al. Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta-analysis[J]. Ultrasound Obstet Gynecol201851(2):169-175.
[9]
王媛媛,陈练,赵扬玉. 利用影像学指标判断胎盘植入患者不良妊娠结局[J]. 中国实用妇科与产科杂志202036(5):416-419.
[10]
Jauniaux E, Chantraine F, Silver RM, et al. FIGO consensus guidelines on placenta accreta spectrum disorders: epidemiology[J]. Int J Gynaecol Obstet2018140(3):265-273.
[11]
Mehrabadi A, Hutcheon JA, Liu S, et al. Contribution of placenta accreta to the incidence of postpartum hemorrhage and severe postpartum hemorrhage[J]. Obstet Gynecol2015125(4):814-821.
[12]
Allen L, Jauniaux E, Hobson S, et al. FIGO consensus guidelines on placenta accreta spectrum disorders: nonconservative surgical management[J]. Int J Gynaecol Obstet2018140(3):281-290.
[13]
Fonseca A, Ayres de Campos D. Maternal morbidity and mortality due to placenta accreta spectrum disorders[J]. Best Pract Res Clin Obstet Gynaecol202172:84-91.
[14]
Schwickert A, van Beekhuizen HJ, Bertholdt C, et al. Association of peripartum management and high maternal blood loss at cesarean delivery for placenta accreta spectrum (PAS): a multinational database study[J]. Acta Obstet Gynecol Scand2021100 Suppl 1:29-40.
[15]
Shamshirsaz AA, Fox KA, Erfani H, et al. Coagulopathy in surgical management of placenta accreta spectrum[J]. Eur J Obstet Gynecol Reprod Biol2019237:126-130.
[16]
Sentilhes L, Kayem G, Chandraharan E, et al. FIGO consensus guidelines on placenta accreta spectrum disorders: conservative management[J]. Int J Gynaecol Obstet2018140(3):291-298.
[17]
American College of Obstetricians and Gynecologists, Society for Maternal-Fetal Medicine. Obstetric care consensus No.7: placenta accreta spectrum[J]. Obstet Gynecol2018132(6):e259-e275.
[18]
Gatta LA, Weber JM, Gilner JB, et al. Transfusion requirements with hybrid management of placenta accreta spectrum incorporating targeted embolization and a selective use of delayed hysterectomy[J]. Am J Perinatol202229(14):1503-1513.
[19]
Ramdhan RC, Loukas M, Tubbs RS. Anatomical complications of hysterectomy: a review[J]. Clin Anat201730(7):946-952.
[20]
O′Brien JM, Barton JR, Donaldson ES. The management of placenta percreta: conservative and operative strategies[J]. Am J Obstet Gynecol1996175(6):1632-1638.
[21]
Jauniaux E, Bunce C, Grønbeck L, et al. Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis[J]. Am J Obstet Gynecol2019221(3):208-218.
[22]
Wang YL, Weng SS, Huang WC. First-trimester abortion complicated with placenta accreta: a systematic review[J]. Taiwan J Obstet Gynecol201958(1):10-14.
[23]
Li J, Zhang Y, Tian F, et al. Subtotal hysterectomy causes fewer long-term detrimental effects on ovary tissues than total hysterectomy[J]. Histol Histopathol2023:1-17.
[24]
Aleixo GF, Fonseca MCM, Bortolini MAT, et al. Total versus subtotal hysterectomy: systematic review and meta-analysis of intraoperative outcomes and postoperative short-term events[J]. Clin Ther201941(4):768-789.
[25]
Neis F, Reisenauer C, Kraemer B, et al. Retrospective analysis of secondary resection of the cervical stump after subtotal hysterectomy: why and when?[J]. Arch Gynecol Obstet2021304(6):1519-1526.
[26]
Michelet D, Ricbourg A, Gosme C, et al. Emergency hysterectomy for life-threatening postpartum haemorrhage: risk factors and psychological impact[J]. Gynecol Obstet Fertil201543(12):773-779.
[27]
Steins Bisschop CN, Schaap TP, Vogelvang TE, et al. Invasive placentation and uterus preserving treatment modalities: a systematic review[J]. Arch Gynecol Obstet2011284(2):491-502.
[28]
Sentilhes L, Kayem G, Ambroselli C, et al. Fertility and pregnancy outcomes following conservative treatment for placenta accreta[J]. Hum Reprod201025(11):2803-2810.
[29]
Abd Elazeem HAS, Saad MM, Ahmed IA, et al. High-intensity focused ultrasound in management of placenta accreta spectrum: a systematic review[J]. Int J Gynaecol Obstet2020151(3):325-332.
[30]
Eshkoli T, Weintraub AY, Sergienko R, et al. Placenta accreta: risk factors, perinatal outcomes, and consequences for subsequent births[J]. Am J Obstet Gynecol2013208(3):219.e1-219.e7.
[31]
Cauldwell M, Chandraharan E, Pinas Carillo A, et al. Successful pregnancy outcome in woman with history of Triple-P procedure for placenta percreta[J]. Ultrasound Obstet Gynecol201851(5):696-697.
[32]
张丽姿,杜丽丽,赵会丹,等. 胎盘植入性疾病孕妇Triple-P手术后的再次妊娠结局分析[J]. 中华妇产科杂志2023(1):44-48.
[1] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[2] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[3] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[4] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[5] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[6] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[7] 李伟, 宋子健, 赖衍成, 周睿, 吴涵, 邓龙昕, 陈锐. 人工智能应用于前列腺癌患者预后预测的研究现状及展望[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 541-546.
[8] 陈樽, 王平, 金华, 周美玲, 李青青, 黄永刚. 肌肉减少症预测结直肠癌术后切口疝发生的应用研究[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 639-644.
[9] 关小玲, 周文营, 陈洪平. PTAAR在乙肝相关慢加急性肝衰竭患者短期预后中的预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 841-845.
[10] 张润锦, 阳盼, 林燕斯, 刘尊龙, 刘建平, 金小岩. EB病毒相关胆管癌伴多发转移一例及国内文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 865-869.
[11] 陈晓鹏, 王佳妮, 练庆海, 杨九妹. 肝细胞癌VOPP1表达及其与预后的关系[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 876-882.
[12] 刘郁, 段绍斌, 丁志翔, 史志涛. miR-34a-5p 在结肠癌患者的表达及其与临床特征及预后的相关性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 485-490.
[13] 陈倩倩, 袁晨, 刘基, 尹婷婷. 多层螺旋CT 参数、癌胚抗原、错配修复基因及病理指标对结直肠癌预后的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 507-511.
[14] 曾明芬, 王艳. 急性胰腺炎合并脂肪肝患者CT 与彩色多普勒超声诊断参数与其病情和预后的关联性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 531-535.
[15] 王景明, 王磊, 许小多, 邢文强, 张兆岩, 黄伟敏. 腰椎椎旁肌的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 846-852.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?